Publication
What M&A trends will transform the 2024 insurance landscape?
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
United States | Publication | June 2022
Alvaro Bedoya’s confirmation has restored a Democratic majority on the Federal Trade Commission. Under a Democratic majority, FTC Chair Khan has the ability to continue to further test novel theories of harm in both merger and non-merger matters generally and in healthcare in particular. Additionally, Commissioner Bedoya’s background in privacy and technology could further broaden the scope of both merger and non-merger investigations. We consider the potential scope of these novel theories of harm as applied to healthcare transactions and conduct.
Read the full CPI Antitrust Chronicle article.
Special thanks to summer associate Antonia Mordino for assisting in the preparation of this article.
Publication
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
Publication
The ongoing conflicts and further geopolitical tensions in Eastern Europe and the Middle East, coupled with upcoming elections in a number of key countries including the US and the UK, make 2024 challenging to predict what impact this will have on the insurance sector.
Publication
On 6 September 2022, the European Commission (EC) prohibited Illumina’s acquisition of Grail, bringing to an end the administrative stage of a legal saga that has attracted interest beyond competition law specialists.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023